Matteo Leoncin
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 3
- Genetics 6
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Renato Zambello (6 shared papers)Gregorio Barilà (5 shared papers)Cristina Vicenzetto (3 shared papers)Gianpietro Semenzato (5 shared papers)Giulia Calabretto (3 shared papers)Antonella Teramo (3 shared papers)Monica Facco (3 shared papers)Anna Chiara Frigo (1 shared paper)
- Journals
- Blood (2 papers)Cancers (1 paper)Frontiers in Oncology (1 paper)Current Oncology Reports (1 paper)Leukemia Research (1 paper)
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Matteo Leoncin
13 papers receiving 133 citations
Peers
Comparison fields: 5 of 26
- Genetics 70
- Hematology 46
- Pathology and Forensic Medicine 63
- Immunology 70
- Public Health, Environmental and Occupational Health 25
Countries citing papers authored by Matteo Leoncin
This map shows the geographic impact of Matteo Leoncin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Leoncin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Leoncin more than expected).
Fields of papers citing papers by Matteo Leoncin
This network shows the impact of papers produced by Matteo Leoncin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Leoncin. The network helps show where Matteo Leoncin may publish in the future.
Co-authors
The 25 scholars most cited alongside Matteo Leoncin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 45 | |
| 2 | 2019 | 27 | |
| 3 | 2022 | 15 | |
| 4 | 2022 | 15 | |
| 5 | 2020 | 7 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 5 | |
| 8 | 2024 | 4 | |
| 9 | 2017 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2017 | 1 | |
| 13 | 2018 | 1 |
About Matteo Leoncin
Matteo Leoncin is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 13 papers that have together received 133 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Genetics (70 citations), Hematology (46 citations), Pathology and Forensic Medicine (63 citations), Immunology (70 citations) and Public Health, Environmental and Occupational Health (25 citations). Matteo Leoncin has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Renato Zambello, Gregorio Barilà, Cristina Vicenzetto, Gianpietro Semenzato, Giulia Calabretto, Antonella Teramo, Monica Facco, Anna Chiara Frigo, Laura Pavan and Vanessa Rebecca Gasparini. Their work appears in journals such as Blood, Cancers, Frontiers in Oncology, Current Oncology Reports and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.